Assessment of Factors Associated With Community-Acquired Extended-Spectrum β-Lactamase-Producing Escherichia coli Urinary Tract Infections in France

被引:11
作者
Paumier, Adeline [1 ]
Asquier-Khati, Antoine [1 ,2 ]
Thibaut, Sonia [3 ]
Coeffic, Thomas [3 ]
Lemenand, Olivier [3 ]
Larramendy, Stephanie [2 ]
Leclere, Brice [4 ,5 ]
Caillon, Jocelyne [3 ]
Boutoille, David [6 ]
Birgand, Gabriel [1 ,3 ,7 ]
机构
[1] Ctr Hosp Univ CHU Le Tourville, Ctr Appui Prevent Infect Associees Soins Pays Loi, Nantes, France
[2] Univ Nantes, Fac Med, Dept Gen Practice, Nantes, France
[3] CHU Le Tourville, PRIMO, French Natl Surveillance Syst Antimicrobial Resis, Nantes, France
[4] Univ Hosp Nantes, Dept Infect Dis, Nantes, France
[5] Inst Natl Sante & Rech Med, Ctr Invest Clin 1413, Nantes, France
[6] CHU Nantes, Dept Med Evaluat & Epidemiol, Nantes, France
[7] Imperial Coll London, Natl Inst Hlth Res, Hlth Protect Res Unit Healthcare Associated Infec, Hammersmith Campus, London, England
基金
英国经济与社会研究理事会;
关键词
RISK-FACTORS; ANTIBIOTIC-RESISTANCE; ENTEROBACTERIACEAE; EPIDEMIOLOGY; POPULATION; CARRIAGE; ANIMALS; GENES; FOOD;
D O I
10.1001/jamanetworkopen.2022.32679
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli is considered a leading pathogen contributing to the global burden of antimicrobial resistance. OBJECTIVE To better understand factors associated with the heterogeneity of community-acquired ESBL-producing E coli urinary tract infections (UTIs) in France. DESIGN, SETTING, AND PARTICIPANTS This cross-sectional study performed from January 1 to December 31, 2021, was based on data collected via PRIMO (Surveillance and Prevention of Antimicrobial Resistance in Primary Care and Nursing Homes), a nationwide dinical laboratory surveillance system in France. Strains of E coli isolated from community urine samples from January 1 to December 31, 2019, from 59 administrative departments of metropolitan France were included. MAIN OUTCOMES AND MEASURES Quasi-Poisson regression models were used to assess the associations between several ecological factors available on government and administration websites between 2010 and 2020 (demographic population structure, living conditions, baseline health care services, antibiotic consumptions, economic indicators, animal farming density, and environmental characteristics) and the number of ESBL-producing Ecoli strains isolated from urine samples of individuals with community-acquired UTI in 2019. RESULTS Among 444 281 E coli isolates from urine samples tested in 1013 laboratories, the mean prevalence of ESBL-producing E coli was 3.0% (range, 1.4%-8.8%). In an adjusted model, the number of community-acquired ESBL-producing E coli UTIs in each department was positively associated with the percentage of children younger than 5 years (adjusted beta(1) coefficient, 0.112 [95% CI. 0.040-0.185]; P = .004), overcrowded households (adjusted beta(1) coefficient, 0.049 [95% CI, 0.034 to 0.062]; P < .001), consumption of fluoroquinolones (adjusted Ri coefficient, 0.002 [95% CI. 0.001-0.002]; P < .001), and tetracyclines (adjusted beta(1 )coefficient, 0.0002 [0.00004 to 0.00039]; P = .02), and poultry density (adjusted beta(1) coefficient, 0.0001[95% CI, 0.0001-0.0002]; P < .001). The social deprivation index (adjusted beta(1) coefficient, -0.115 [95% CI. -0.165 to -0.064]; P < .001) and the proportion of water surface area (adjusted beta(1)coefficient. -0.052 [-0.081 to -0.024]; P = .001) were negatively associated with a higher number of community-acquired ESBL-producing E coli UTIs. CONCLUSIONS AND RELEVANCE The findings of this cross-sectional study suggest that multiple human health, animal health, and environmental factors are associated with the occurence of community-acquired ESBL E coli UTI. Strategies to mitigate ESBL in the community should follow the One Health approach and address the role played by fluoroquinolones, tetracycline use, poultry density, overcrowded households, and preschool-aged children.
引用
收藏
页数:13
相关论文
共 37 条
[1]  
Agence Nationale de la Cohesion des Territoires, 2019, OBS TERR
[2]  
[Anonymous], 2021, Demographie des professionnels de sante
[3]  
[Anonymous], 2020, CHIFFRES POPULATIONS
[4]  
[Anonymous], 2019, AGRESTE STAT AGRICOL
[5]  
Anses: Agence nationale du medicament veterinaire, 2020, SUIV VENT MED VET CO
[6]   Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study [J].
Arcilla, Maris S. ;
van Hattem, Jame M. ;
Haverkate, Manon R. ;
Bootsma, Martin C. J. ;
van Genderen, Perry J. J. ;
Goorhuis, Abraham ;
Grobusch, Martin P. ;
Lashof, Astrid M. Oude ;
Molhoek, Nicky ;
Schultsz, Constance ;
Stobberingh, Ellen E. ;
Verbrugh, Henri A. ;
de Jong, Menno D. ;
Melles, Damian C. ;
Penders, John .
LANCET INFECTIOUS DISEASES, 2017, 17 (01) :78-85
[7]   Limited Dissemination of Extended-Spectrum β-Lactamase- and Plasmid-Encoded AmpC-Producing Escherichia coli from Food and Farm Animals, Sweden [J].
Borjesson, Stefan ;
Ny, Sofia ;
Egervarn, Maria ;
Bergstrom, Jakob ;
Rosengren, Asa ;
Englund, Stina ;
Lofmark, Sonja ;
Byfors, Sara .
EMERGING INFECTIOUS DISEASES, 2016, 22 (04) :634-640
[8]   Wastewater Treatment Plants Release Large Amounts of Extended-Spectrum β-Lactamase-Producing Escherichia coli Into the Environment [J].
Brechet, Caroline ;
Plantin, Julie ;
Sauget, Marlene ;
Thouverez, Michelle ;
Talon, Daniel ;
Cholley, Pascal ;
Guyeux, Christophe ;
Hocquet, Didier ;
Bertrand, Xavier .
CLINICAL INFECTIOUS DISEASES, 2014, 58 (12) :1658-1665
[9]  
Cafdata l'Open Data des Allocations Familiales, 2019, NOMBR PLAC TYP MOD A
[10]   Practice guidelines for the management of adult community-acquired urinary tract infections [J].
Caron, F. ;
Galperine, T. ;
Flateau, C. ;
Azria, R. ;
Bonacorsi, S. ;
Bruyere, F. ;
Cariou, G. ;
Clouqueur, E. ;
Cohen, R. ;
Doco-Lecompte, T. ;
Elefant, E. ;
Faure, K. ;
Gauzit, R. ;
Gavazzi, G. ;
Lemaitre, L. ;
Raymond, J. ;
Senneville, E. ;
Sotto, A. ;
Subtil, D. ;
Trivalle, C. ;
Merens, A. ;
Etienne, M. .
MEDECINE ET MALADIES INFECTIEUSES, 2018, 48 (05) :327-358